Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia

ConclusionPUL is a well-tolerated, minimally invasive therapy for BPH that provides favorable and durable symptomatic, sexual health, and functional outcomes up to 24  months. Longer follow-up and randomized studies comparing to current standards are required to further confirm the long-term sustainability of PUL.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research